Reprogramming of endothelial gene expression by tamoxifen inhibits angiogenesis and ERα-negative tumor growth.

Publication Year: 2024

DOI:
10.7150/thno.87306

PMCID:
PMC10750193

PMID:
38164151

Journal Information

Full Title: Theranostics

Abbreviation: Theranostics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"fastq files are accessible through the geo portal under the gse219159 accession number."

Code Sharing
Evidence found in paper:

"Competing Interests: The authors have declared that no competing interest exists."

Evidence found in paper:

"Funding The work at INSERM U1297 was supported by INSERM, CHU and Université de Toulouse III, Faculté de Médecine Toulouse-Rangueil, Fondation pour la Recherche Médicale and Region-Occitanie- MP 0014573- FEDER-REGEN-EVE. C.F. was funded by ANR-18-CE14-0016/ ESTROSHEAR and Ligue Nationale contre la Cancer. Work at the CNRS UMR6290 was supported by the CNRS and the University of Rennes. Research by B.S.K. and J.A.K. was supported by National Institutes of Health/NCI grant CA220484 and grants BCRF-083 and BCRF-084 from the Breast Cancer Research Foundation."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025